Why Medicare Coverage for Hearing Aids Forces Seniors Into Private Plans

Last updated 4 months ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.

A reader writes to us:

Why does the government force the elderly who are already on a fixed budget to pay for a Medicare Advantage (Part C) plan to get coverage for hearing aids and related services.

Most hearing loss cannot be reversed.

Age- and noise-related hearing loss are common among the elderly and can affect quality of life.

For millions of older Americans, the path to obtaining affordable hearing aids leads to a fundamental crossroads in the nation’s primary health insurance program for the elderly.

The core issue: Original Medicare, the foundational government-run program, explicitly denies coverage for hearing aids. This forces many seniors, often living on fixed incomes, to navigate the complex private insurance market of Medicare Advantage to find a plan that will help pay for these critical devices.

This coverage gap exists because Medicare treats hearing loss not as a critical medical issue, but as an ancillary problem to be solved outside the bounds of traditional government health insurance.

The Foundation of Medicare and Its Coverage Gap

Original Medicare: A 1965 Focus on Acute Medical Crises

Original Medicare, also known as traditional Medicare, is the federal health insurance program established in 1965 for individuals aged 65 and older, as well as for younger people with certain disabilities. It is a fee-for-service program administered directly by the federal government, comprising two main parts: Part A and Part B.

Part A, often called Hospital Insurance, is designed to cover major inpatient medical events. Its benefits primarily include care received in a hospital, limited stays in a skilled nursing facility following a hospital stay, hospice care for the terminally ill, and some home health care services.

Part B, or Medical Insurance, complements this by covering a wide range of outpatient services. This includes visits to doctors and other healthcare providers, outpatient hospital care, ambulance services, preventive services like flu shots and cancer screenings, and durable medical equipment such as wheelchairs and walkers.

The architecture of this program reflects the specific crisis it was created to solve. In the early 1960s, a growing population of older Americans faced a dire situation: the cost of hospital care was rising dramatically, and private insurers increasingly viewed the elderly as a “bad risk,” making comprehensive, affordable coverage nearly impossible to obtain.

The primary goal of the Social Security Amendments of 1965, which created Medicare, was to provide a safety net against the financially catastrophic costs of acute medical care. The program’s architects prioritized coverage for hospital stays and physician services, as these were seen as the most unpredictable and costly components of healthcare at the time.

The Statutory Exclusions: Why Hearing, Dental, and Vision Were Left Behind

From its inception, the Medicare program has contained explicit exclusions for certain categories of care, most notably hearing, dental, and vision services. This was not an oversight but a deliberate legislative choice rooted in the historical context and policy priorities of the 1960s.

The legal basis for this is found directly in the Social Security Act of 1965, which states that no payment shall be made for, among other things, “hearing aids or examinations therefor.”

The rationale behind this exclusion stems from a fundamental distinction made by the law’s creators between “medical” conditions and “routine” aspects of aging. In the 1960s, hearing loss, much like the need for eyeglasses or routine dental cleanings, was widely perceived as a normal, inevitable consequence of growing older rather than a treatable medical pathology with cascading health effects.

The program was designed to shield seniors from the high costs of acute illness and injury, not to manage chronic conditions or enhance quality of life through assistive devices.

Cost was also a significant factor. By focusing on what were considered the most essential and financially devastating medical expenses, policymakers could limit the program’s initial scope and cost. The prevailing view was that if Medicare could protect seniors from bankruptcy due to a hospital stay, they would be better able to afford these other, seemingly more predictable expenses out-of-pocket.

This foundational decision, which legally categorized hearing aids alongside “routine physical checkups” and eyeglasses, established a legal and philosophical framework that has persisted for nearly six decades, even as modern medical science has comprehensively demonstrated the profound health consequences of untreated hearing loss.

The Modern-Day Impact of a Decades-Old Decision

Today, the legacy of this 1965 decision continues to define the boundaries of Original Medicare coverage for the 67 million people enrolled in the program. The list of services not covered by Original Medicare remains largely unchanged and includes:

• Routine hearing exams and hearing aids
• Most dental care, including cleanings, fillings, tooth extractions, and dentures
• Routine eye exams for prescribing glasses or contact lenses
• Long-term custodial care in nursing homes or assisted living facilities

This creates a significant gap in coverage. For hearing care specifically, it means that a beneficiary with Original Medicare must pay 100% of the cost for hearing aids and the exams required to fit them. This policy forces millions of seniors into a difficult choice: forgo necessary care due to cost, pay thousands of dollars out-of-pocket, or seek an alternative form of coverage.

This gap in the public, government-run program is the primary driver behind the growth of its private-sector alternative: Medicare Advantage.

The Rise of Medicare Advantage: A Private Sector Solution

A New Path: The Evolution of Medicare Part C

As the limitations of Original Medicare became more apparent over the decades, the federal government created an alternative pathway for beneficiaries to receive their benefits through private insurance companies. This system is known as Medicare Advantage, or Part C.

These plans are offered by private, Medicare-approved companies like Humana, UnitedHealthcare, and Aetna, which are paid by the federal government to provide all Part A and Part B benefits, and often Part D (prescription drug) benefits, in a single “bundled” package.

The concept of using private managed care plans within Medicare has roots in the 1970s, but it was formally established as the “Medicare+Choice” program under the Balanced Budget Act of 1997. The program was rebranded and significantly expanded as Medicare Advantage in 2003, which also introduced the Part D prescription drug benefit.

Since then, enrollment has grown exponentially. In 2024, more than half of all eligible Medicare beneficiaries—33.8 million people—are enrolled in a Medicare Advantage plan, a dramatic shift away from the traditional government-run program.

This explosive growth is not accidental. It is a direct market response to the coverage gaps left by Original Medicare, with the inclusion of supplemental benefits like hearing, dental, and vision coverage being a primary driver of enrollment.

The Business of Benefits: How Rebates Fund Hearing Aids

The ability of private Medicare Advantage plans to offer benefits that the public Medicare program cannot is rooted in a unique funding mechanism involving government payments, competitive bidding, and shared savings known as “rebates.” This system creates a powerful business model where private insurers are financially rewarded for capitalizing on the shortcomings of the public program.

The process works in several steps:

Government Payments and Benchmarks: The Centers for Medicare & Medicaid Services (CMS) sets a maximum amount, or “benchmark,” that it will pay a private plan to cover a beneficiary in a specific county for a year. This benchmark is calculated as a percentage of what it would typically cost to cover a similar beneficiary under Original Medicare in that same county.

The Bidding Process: Each year, insurance companies submit a “bid” to CMS. This bid represents their estimated cost to provide all Part A and Part B services to an average beneficiary. Thanks to the efficiencies of managed care and negotiated provider rates, these bids are often significantly lower than the government’s benchmark.

Generating Rebates: When a plan’s bid is lower than the county benchmark, the plan and the government share the savings. The portion of the savings that goes back to the plan is called a “rebate.”

Funding Supplemental Benefits: By law, plans must use these rebate dollars to directly benefit their enrollees. This is where the funding for extra benefits comes from. Plans can use the rebate money to lower monthly premiums (many plans have a $0 premium beyond the standard Part B premium), reduce cost-sharing like copays and deductibles, or offer coverage for services not included in Original Medicare—most notably, hearing, dental, and vision care.

This rebate system has become a massive source of funding for these extra benefits. In 2023, rebates used to provide additional benefits reached a historic high of $196 per enrollee per month.

The hearing aid benefit, therefore, is not an act of corporate generosity but a core component of the Medicare Advantage business model. It is a calculated, financially-driven marketing tool that directly leverages the statutory gaps in Original Medicare to attract and retain members.

A Closer Look at MA Hearing Benefits: A Spectrum of Coverage

While Medicare Advantage plans present a crucial pathway to hearing aid coverage for millions, the benefits they offer are far from uniform and often come with significant limitations that beneficiaries must carefully navigate. The promise of “hearing coverage” can vary dramatically from one plan to another.

Common limitations and variations include:

Network Restrictions: Most Medicare Advantage plans operate as Health Maintenance Organizations (HMOs) or Preferred Provider Organizations (PPOs). This means that to receive the maximum benefit, enrollees must see audiologists and hearing aid dispensers who are part of the plan’s network. Going out-of-network can result in much higher costs or no coverage at all.

Annual Dollar Limits: Plans typically do not cover the full cost of hearing aids. Instead, they provide an allowance or a fixed dollar amount per ear. A Kaiser Family Foundation (KFF) study found that in 2021, the average annual limit for hearing aid coverage was just $960, a figure that falls far short of the typical multi-thousand-dollar cost of a pair of prescription devices.

Frequency Limits: Coverage is often restricted to one pair of hearing aids over a set period. While some plans allow for a new pair each year, many limit this benefit to once every two or even three years.

Cost-Sharing: Even with coverage, beneficiaries almost always face out-of-pocket costs in the form of copayments. These copays can be substantial, often tiered based on the technology level of the hearing aid. For example, a plan might require a copay of $699 for an “advanced” level hearing aid and $999 for a “premium” level device.

Low Utilization: Despite the high value beneficiaries place on these supplemental benefits, actual usage rates can be surprisingly low. A 2025 Commonwealth Fund survey found that only 7% of Medicare Advantage enrollees reported using their hearing benefits in the past year. Barriers to use can include a lack of awareness of the benefit, difficulty navigating the plan’s rules, or finding the remaining out-of-pocket costs still unaffordable.

The Public Health Imperative: Reclassifying Hearing Loss as Critical

The Scope of the Problem: Age-Related Hearing Loss by the Numbers

The decision in 1965 to exclude hearing care from Medicare was based on a perception of hearing loss as a non-critical part of aging. Modern public health data paints a starkly different picture, revealing a widespread and undertreated chronic condition with severe consequences.

Age-related hearing loss, or presbycusis, is one of the most common health conditions affecting older Americans. The statistics are staggering:

• Approximately one in three adults between the ages of 65 and 74 has hearing loss
• The prevalence rises sharply with age, affecting more than half of those 75 and older
• A 2023 survey found that nearly two-thirds of adults aged 71 and older had hearing loss, and by age 90, it is nearly universal, affecting 96.2% of individuals

Overall, hearing loss is the third most common chronic physical condition in the United States, trailing only hypertension and arthritis.

Despite its prevalence, hearing loss remains profoundly undertreated. According to the National Institute on Deafness and Other Communication Disorders (NIDCD), while approximately 28.8 million U.S. adults could benefit from hearing aids, fewer than one in five actually use them. This treatment gap is a direct consequence of the financial and systemic barriers to care, primarily the lack of coverage under Original Medicare.

Beyond Sound: The Cascade of Consequences from Untreated Hearing Loss

A robust and growing body of scientific evidence has transformed our understanding of hearing loss from a simple inconvenience to a critical public health issue with a profound impact on overall health, brain function, and safety. Research from leading institutions like Johns Hopkins University has demonstrated a clear and alarming link between untreated hearing loss and a cascade of adverse health outcomes.

Cognitive Decline and Dementia: Perhaps the most significant finding is the strong association between hearing loss and accelerated cognitive decline. A landmark 2020 report from the Lancet Commission identified hearing loss in mid-life as the single largest potentially modifiable risk factor for developing dementia.

Studies from Johns Hopkins researchers found that individuals with mild hearing loss had double the risk of dementia, while those with severe hearing loss were five times more likely to develop the condition. The ACHIEVE study, a large-scale randomized controlled trial, found that for older adults already at increased risk for cognitive decline, treating their hearing loss with hearing aids slowed the rate of cognitive decline by 48% over three years.

Depression, Anxiety, and Social Isolation: The inability to communicate effectively takes a severe toll on mental health. A major study by the National Council on Aging (NCOA) found that seniors with untreated hearing loss were significantly more likely to report depression, anxiety, and paranoia compared to those who used hearing aids.

The frustration and embarrassment of constantly struggling to follow conversations often leads individuals to withdraw from social activities, resulting in profound loneliness and social isolation.

Increased Risk of Falls and Hospitalization: Hearing is crucial for spatial awareness and balance. Research has shown that even a mild degree of hearing loss is associated with a threefold increase in the risk of falling. These falls are a leading cause of injury, disability, and costly hospitalizations among older adults. One study found that older adults with hearing loss are 32% more likely to require hospitalization.

The Economic Case for Coverage: Could Treating Hearing Loss Save Medicare Money?

The exclusion of hearing aids from Medicare was originally intended, in part, to control program costs. However, a compelling economic argument suggests this policy may be fiscally shortsighted. By failing to cover the relatively low-cost intervention of hearing aids, Medicare ends up paying far more to treat the expensive, long-term consequences of untreated hearing loss.

The policy of non-coverage leads to low treatment rates, which in turn contributes to a higher incidence of falls, hospitalizations, cognitive decline, and dementia—all of which are conditions that Medicare does cover and that are extremely expensive to treat.

A pivotal 2018 cross-sectional analysis from researchers at Johns Hopkins Bloomberg School of Public Health provides direct evidence for this economic argument. The study compared Medicare spending for beneficiaries with hearing aids who used hearing care services against a matched group who also had hearing aids but did not use hearing care services.

The results were striking: average annual Medicare spending was $2,513 lower per person for the group that utilized hearing care services ($8,196 vs. $10,709). The difference in spending was driven primarily by lower costs for skilled nursing facility care and home health services—plausible outcomes of better health management and fewer injurious falls.

While more research is needed, this study strongly suggests that providing coverage for hearing care is not just a cost, but an investment that could yield significant net savings for the Medicare program. By treating the root cause, Medicare could potentially avoid or delay the onset of far more expensive medical complications, making the current policy of exclusion both detrimental to public health and economically inefficient.

The Financial Burden on America’s Seniors

The High Cost of Hearing: An Analysis of Out-of-Pocket Expenses

For the majority of Medicare beneficiaries who rely on the traditional program, the statutory exclusion of hearing aids translates into a significant financial barrier. The out-of-pocket costs for hearing aids and the professional services required to fit and maintain them are substantial, placing them out of reach for many seniors living on fixed incomes.

The price of prescription hearing aids varies widely depending on the technology level, features, and brand, but typically ranges from $2,000 to $7,000 for a pair. A single device can cost anywhere from $1,000 to over $3,500.

This high price is often attributed to the continuous research and development invested by manufacturers and a “bundled” pricing model, where the cost of the device is combined with the professional services of the audiologist. These services are critical for a successful outcome and include the initial hearing evaluation, custom fitting and programming of the device, follow-up adjustments, and ongoing maintenance.

For a senior on a fixed budget, this multi-thousand-dollar expense can be prohibitive. A KFF analysis found that the average Medicare beneficiary who used hearing care services in 2018 paid $914 out-of-pocket, with 10% of users spending $3,600 or more. This high cost is a primary reason why so many who need hearing aids do not get them.

Navigating a Complex Market: From Prescription Devices to Over-the-Counter Options

In an effort to improve access and affordability, the U.S. Food and Drug Administration (FDA) in 2022 created a new category of over-the-counter (OTC) hearing aids. These devices are available for purchase directly by consumers without the need for an exam or prescription from a hearing healthcare professional. They are intended for adults with perceived mild to moderate hearing loss and are generally much less expensive than prescription devices, with prices ranging from a few hundred to a couple of thousand dollars.

While the availability of OTC hearing aids is a positive step toward lowering costs for some, it is not a comprehensive solution. These devices are not suitable for individuals with severe or profound hearing loss, or for those with more complex hearing needs that require professional diagnosis and custom programming.

Furthermore, Original Medicare does not provide any coverage or reimbursement for OTC hearing aids. Some Medicare Advantage plans may offer an allowance for OTC products as part of their broader supplemental benefits, but this is not a standard feature across all plans.

The Path Forward: Legislative Debates and Politics of Coverage

A History of Inaction and Recent Momentum

The effort to add hearing, dental, and vision coverage to Original Medicare is not new. For decades, patient advocates and some members of Congress have introduced legislation to close these coverage gaps, but these attempts have consistently failed to become law. The political and fiscal challenges have proven formidable.

However, there has been a recent increase in momentum, driven by the growing body of research on the public health consequences of untreated hearing loss and the increasing political power of the senior population. A significant recent effort occurred during the 117th Congress (2021-2022) as part of the Build Back Better Act. The House of Representatives passed a version of the bill that included a new hearing benefit under Medicare.

The proposal would have covered hearing aids for individuals with moderately severe to profound hearing loss once every five years. Despite this progress, the provision was ultimately stripped from the final package, and the broader legislation failed to pass the Senate.

Despite this setback, the push for coverage continues with strong bipartisan support. Several bills have been introduced in the current Congress that aim to address the issue, signaling a persistent and growing recognition among policymakers that the status quo is untenable.

In Focus: The Medicare Hearing Aid Coverage Act of 2025

The leading legislative effort to address this issue is the Medicare Hearing Aid Coverage Act of 2025 (H.R. 500), a bipartisan bill introduced by Representatives Debbie Dingell (D-MI) and Brian Fitzpatrick (R-PA). The bill’s approach is direct and simple, aiming to correct the original 1965 exclusion.

Proposed Legal Change: The core of the bill is a single amendment to Section 1862(a)(7) of the Social Security Act. It proposes to strike the phrase “hearing aids or examinations therefor,” from the list of excluded services. This clean removal would eliminate the legal barrier that has prevented Medicare from covering these items for nearly 60 years.

Effective Date: If passed, the new coverage would apply to hearing aids and related services furnished to beneficiaries on or after January 1, 2026.

Mandated GAO Study: The bill also directs the Government Accountability Office (GAO), a non-partisan congressional watchdog, to conduct a comprehensive study of all existing programs—both federal and private—that provide assistance for hearing aids. The GAO would be required to report back to Congress within 18 months of the law’s effective date with an analysis of the effectiveness of these programs and recommendations for improvement, including the potential creation of new programs to better meet the needs of individuals with hearing loss.

The Political Battlefield: Voices of Advocacy, Industry, and Government

The legislative battle over adding a hearing benefit to Original Medicare is not merely a debate over a single line item in the federal budget. It is a proxy war over the future of Medicare itself, pitting a clear public health imperative against the powerful financial interests of the private insurance industry, which has built a thriving market based on the public program’s limitations.

Patient and Health Advocates: A broad coalition of organizations strongly supports expanding Original Medicare to include hearing coverage. Groups like the Center for Medicare Advocacy, the National Committee to Preserve Social Security and Medicare, AARP, and the Hearing Loss Association of America frame this as a fundamental issue of health equity, dignity, and independence for seniors. They argue that the high cost of hearing aids makes them inaccessible for millions and that coverage is essential to prevent the associated health risks of isolation, cognitive decline, and falls.

Healthcare Professionals: Professional associations, such as the American Speech-Language-Hearing Association (ASHA), are deeply involved in advocacy efforts. Their goals are twofold: to expand beneficiary access to care and to ensure that audiologists are recognized as key practitioners within the Medicare system, able to provide their full scope of services without unnecessary barriers like physician referrals.

The Insurance Industry Lobby: The primary force opposing changes that would strengthen Original Medicare is the private insurance industry. Powerful lobbying groups such as AHIP (America’s Health Insurance Plans) and the Better Medicare Alliance—which represents Medicare Advantage plans—are engaged in “seven-figure lobbying blitzes” to protect the MA market.

Their central argument is that any policy change that might lead to a reduction in the payments or rebates that fund their supplemental benefits is a “cut” to Medicare that will harm seniors. Adding a comprehensive hearing benefit to Original Medicare would eliminate one of the key competitive advantages that MA plans use to attract enrollees, potentially slowing the growth of their highly profitable market. This creates a powerful incentive to maintain the status quo.

This dynamic results in a political stalemate. Policymakers are caught between the overwhelming scientific and public health evidence that supports expanding coverage and the intense political and financial pressure from an industry that thrives on the very existence of the coverage gap. The slow progress on legislation like the Medicare Hearing Aid Coverage Act is a direct consequence of this fundamental conflict between public health needs and private market incentives.

Our articles make government information more accessible. Please consult a qualified professional for financial, legal, or health advice specific to your circumstances.